about
Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placentaCiona intestinalis nuclear receptor 1: a member of steroid/thyroid hormone receptor familyIncreased expression of urokinase plasminogen activator and its cognate receptor in human seminomasEarly discharge after total thyroidectomy: a retrospective feasibility studyA new aurora in anaplastic thyroid cancer therapy.Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.Natural killer cells and nitric oxide.Q-elastography in the presurgical diagnosis of thyroid nodules with indeterminate cytologyDeregulated expression of Aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients.Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate NodulesVirilizing leydig-sertoli cell ovarian tumor associated with endometrioid carcinoma of the endometrium in a postmenopausal patient: case report and general considerations.Lack of Influence of the Androgen Receptor Gene CAG-Repeat Polymorphism on Clinical and Electrocardiographic Manifestations of the Brugada Syndrome in Man.Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues.Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy.The urokinase plasminogen activator system: a target for anti-cancer therapy.Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.Emerging molecular markers for the prognosis of differentiated thyroid cancer patients.Molecular basis of thyrotropin and thyroid hormone action during implantation and early development.New perspectives in the diagnosis of thyroid follicular lesions.Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.The combination of RAF265, SB590885, ZSTK474 on thyroid cancer cell lines deeply impact on proliferation and MAPK and PI3K/Akt signaling pathways.Nodular thyroid disease in the elderly: novel molecular approaches for the diagnosis of malignancy.Deregulated expression of VHL mRNA variants in papillary thyroid cancer.Effects of ultraviolet radiation on FRTL-5 cell growth and thyroid-specific gene expression.CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval.Iodine deficiency in pregnant women residing in an area with adequate iodine intake.Consumption of iodized salt may not represent a reliable indicator of iodine adequacy: Evidence from a cross-sectional study on schoolchildren living in an urban area of central Italy.Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas.Expression and prognostic value of the cell polarity PAR complex members in thyroid cancer.Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes.High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10.Vitiligo and Autoimmune Thyroid Disorders.Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine.Early thyroid hormone treatment in rats increases testis size and germ cell number.Thyroid hormone regulates protease expression and activation of Notch signaling in implantation and embryo development.Association of epicardial fat thickness with the severity of obstructive sleep apnea in obese patients.Severe oligozoospermia in a young man with chronic myeloid leukemia on long-term treatment with imatinib started before puberty.
P50
Q22253254-4E2C7965-B6A0-452E-8417-C8A705D41452Q32021982-D4017B3F-3F19-4424-89B8-C8719F054529Q33559079-58968401-2996-4079-ABEA-9B7088E4BF3AQ33894055-5969E0E0-17CD-4415-ADAD-A8F4A7EE787BQ33930368-EC75DA78-D8AC-4BD1-B1DB-0CF369E5D81BQ34029020-ABAA52B8-21F7-4CED-AFEC-2AD67FE7BF38Q34342650-0D121965-2453-49A6-816C-F6C867AA16D6Q34500672-882CAF0F-A7A8-43B6-9654-3ACD0AA3371CQ35217023-B9BF764B-9B49-4D00-BC5E-E3ABE4986F56Q36324723-81CD1E10-C1A8-40B2-8609-9B3CB7F162FDQ36371563-63A88864-3B46-426F-BA0D-7CA5DC1377E8Q36371585-11D637F8-5334-42C8-A3FF-A84F685CC595Q36410625-C9C1EE80-8807-445E-8FC3-42B0CE3DCFAEQ37362970-5979F2BD-9DE3-4FCB-BCE7-F817D9BE4E8BQ37387695-866B53E7-328E-4E6F-AA72-65C74057AAECQ37734435-4F0A09E5-229E-420C-8017-6B072E27D7D1Q38215024-3620569F-1A36-4175-87EF-31401969AFC0Q38221431-F794F9B7-ED03-4AC3-9515-A114311CDE83Q38785223-56476A71-ADBD-4700-A93F-DF042DD3FD95Q38848857-E082A2F4-3D91-409E-BEB7-95D10561F6E1Q38960074-8635CDA4-33C1-4ED1-A198-2B210BABBD0FQ38995628-7383A081-ED95-4ACC-8FD7-A4D085096581Q39004661-8C23560B-9C5B-4275-8693-AF756C38BF35Q39019458-74CE336E-0DD0-411A-A861-BF22B0E1AED5Q39148679-817513FE-3774-4A87-AA5F-7DE53CC9E735Q39175682-55870B40-8C47-42A6-9872-4FC0C2B5F263Q39330634-4636ABDE-A185-43DA-B14A-CC32F608C387Q39838658-B0DDA5C4-5D84-4D9B-85E4-57B052FA4523Q39982308-72241E01-1C7F-4574-8D18-8CD1829684EAQ40240404-B7857B75-FBF5-4250-98CB-166149B70CBEQ40275379-61749879-0EC1-4327-B2CD-2E31222CB744Q40316542-38FF5EE4-FCB9-4BEE-8498-8F114D7D1EAFQ43893563-AE4AEF89-F3E9-46B8-9330-5FE35402D251Q45902559-140FB79D-A092-46C4-86A7-A8754826A174Q46256690-FA5714F4-11A6-444D-AA5F-3727CF91F765Q47111493-9178AFF4-C71E-4727-A9F7-62C58DD0FA80Q47392224-CEA6A30F-F92E-431E-B9B8-9CE91FCDD5FDQ47674813-3D8D1FDE-B459-4CD4-8CE6-55D4B386E5D3Q48237145-B287A2CC-D766-485D-BCCB-0487AED2C8E4Q51749806-AF33C4F5-012C-4175-8381-E8C230D08338
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvatore Ulisse
@ast
Salvatore Ulisse
@en
Salvatore Ulisse
@es
Salvatore Ulisse
@nl
Salvatore Ulisse
@sl
type
label
Salvatore Ulisse
@ast
Salvatore Ulisse
@en
Salvatore Ulisse
@es
Salvatore Ulisse
@nl
Salvatore Ulisse
@sl
prefLabel
Salvatore Ulisse
@ast
Salvatore Ulisse
@en
Salvatore Ulisse
@es
Salvatore Ulisse
@nl
Salvatore Ulisse
@sl
P106
P1153
7004684082
P21
P31
P496
0000-0002-7573-0759